Augsburg University

Idun
Theses and Graduate Projects

2018

Does music therapy decrease agitation in patients
with dementia?
Clinton Billhorn
Augsburg University

Follow this and additional works at: https://idun.augsburg.edu/etd
Part of the Geriatrics Commons
Recommended Citation
Billhorn, Clinton, "Does music therapy decrease agitation in patients with dementia?" (2018). Theses and Graduate Projects. 363.
https://idun.augsburg.edu/etd/363

This Open Access Thesis is brought to you for free and open access by Idun. It has been accepted for inclusion in Theses and Graduate Projects by an
authorized administrator of Idun. For more information, please contact bloomber@augsburg.edu.

Does music therapy decrease agitation in patients with dementia?
By
Clinton Billhorn, PA-S
Advisor: Vanessa Bester, PA-C

Paper Submitted in Partial Fulfillment
Of the Requirements for the Degree
Of Master of Science
Physician Assistant Studies

Augsburg College
7/6/17

Tables of Contents

Introduction
Background: Literature Review
Methods
Discussion
Conclusion
References
Appendix

3
4
9
10
14
15
17

Introduction
Dementia is an encompassing word that includes specific symptoms which alter a
patient’s problem-solving ability, decision making capacity, and personality.1 Personality
changes, otherwise known as Behavioral and Psychotic Symptoms of Dementia (BPSD) can have
negative impacts on caregivers and families. BPSD can include agitation, depression, elation,
and hallucinations.2 Agitation is generally defined as inappropriate verbal, vocal, or motor
behavior that is not based in a direct need or confusion.3 Agitation towards a caregiver can
result in mistrust, poor psychosocial relationships, and violence. As dementia progresses,
agitation is the most significant factor in patient and caregiver distress.4
According to the Alzheimer’s Association, it is estimated that 5.5 million Americans in
2017 are living with Alzheimer’s Dementia.5 This number is anticipated to increase over the
next ten years. One study suggests that agitation is present in 50.4% of patients with
dementia.6 Due to the high prevalence of agitation, it is important to note that agitation is a
strong predictor of poor quality of life (QOL) and nursing home admission.6 To reduce caregiver
burden and improve QOL, agitation should be treated. The current standard treatment for
dementia does not affect BPSD, instead antipsychotic medications which carry harsh side effect
profiles must be used.1 Current research is focused on identifying non-pharmacologic methods
for treatment of BPSD to avoid adverse events caused by current prescribing and treatment
practices.
Music therapy has been proposed as a non-pharmacologic treatment for BPSD in
patients with dementia. Music therapy has been defined as ‘application of music and/or its
elements by a qualified musical therapist in order to support and stimulate various aspects of

cognitive, emotional, social and physical needs.’2 Researchers have also suggested that
individualized music therapy may have a stronger impact on BPSD. The term individualized
music refers to music that is familiar and known to be enjoyable to the patient. To date, a
concrete mechanism has not been identified that would explain the proposed impact of music
therapy on BPSD in patients with dementia. The working theory is that the brain consists of a
default mode network (DMN).7 The DMN is not clearly understood, but it is believed that
atrophy of the DMN correlates to cognitive and emotional impairment, ultimately leading to
BPSD.7 Listening to music has been shown to activate the DMN, leading researchers to believe
that this could strengthen and prevent atrophy of the DMN.7 Utilizing this proposed
mechanism, music therapy’s activation of the DMN could treat BPSD. Although this has been
accepted as the working mechanism, current research focuses on the impact of music therapy
on BPSD without looking at the physiologic and neurologic basis behind the effect.
This research is intended to identify whether or not music therapy decreases agitation in
patients with dementia. This paper may serve as a centralized assessment of some of the
current studies pertaining to music therapy’s impact on agitation. The goal is to provide
evidence based recommendations on whether music therapy should be incorporated into
treating BPSD, specifically agitation, secondary to dementia.

Background: Literature Review
Providers who manage patients with dementia increasingly recommend nonpharmacologic treatments for agitation.2 Multiple non-pharmacologic modalities have been
proposed to reduce agitation, but evidence of efficacy is lacking. Music therapists,
psychologists, and researchers have conducted randomized controlled trials, systematic

reviews, and observational studies in an effort to determine if music therapy can be utilized to
reduce agitation. This literature review contains a synthesis of current research on music
therapy and agitation secondary to dementia and its impact in relation to provider of
treatment, timeline, and varying environments. The overarching goal is to provide information
that will serve as the basis of discussion.
Caregiver v. Music Therapist
Caregiver and family feedback has suggested that music therapy can be an effective
treatment. A qualitative study (n=12) observed that when music therapy has been administered
by the caregiver or family member, a short-term reduction in agitation has been noted.8 When
a caregiver administered individualized music therapy determined by using the Assessment of
Personal Music Preference (APMP) in a quantitative study (n=42), agitation was lower after
listening to thirty minutes of music during reportedly peak BPSD times when measured by a
modified version of the Cohen-Mansfield Agitation Inventory (CMAI) (p<0.05).9 Alternatively,
researchers looked at the effectiveness of music therapy when provided by trained music
therapists (MTs). A mixed-method feasibility study (n=17) based on interviews, caregiver
feedback, and evaluations administered by two trained MTs showed a significant decrease in
agitation at baseline and seven months following treatment (-25.52; -39.10-11.95).10 A
quantitative exploratory study (n=132) performed by music therapists using group therapy
found a reduction in agitation measured by CMAI (p<0.05).11 A similar quantitative study (n=45)
looking at the efficacy of music therapy administered by MTs found that agitation decreased
when compared to themselves (p<0.05), but a significant reduction was not found when
compared to the control group upon analysis of CMAI scores (p=0.432). 12 While data largely

supports the efficacy of music therapy when provided by MTs, studies have not been done to
demonstrate that they obtain higher reductions in agitation than family or caregiver
administration.
Individualized v. General
Some researchers postulate that individualized music therapy is more effective in
reducing agitation and the available data supports this claim. A qualitative study that looked at
challenges and solutions to treating agitation in dementia found that the effect on agitation
was stronger if music was based on patient preference.13 A similar quantitative study of
participants (n=39) with severe dementia found that interactive, individualized music was
better than passive, generalized forms of music therapy when assessed using the Faces and
Interactive scales (p<0.025).14 Passive meaning simply listening to music, rather than engaging
in singing or rhythmic activities. Although general or individualized music therapy appears to be
effective when administered by a caregiver, individualized music therapy provides a reduction
in agitation during times that are of highest distress to both the patient and the caregiver. Data
supports the use of individualized music therapy over general, but does not discount the impact
that general music therapy can have should that be the only available option.
Agitation and Environment
Impact on frequency of agitation versus severity was compared in one quantitative trial
(n=42). It found that the frequency of BPSD when measured by the CMAI did not decline
(p=0.378), but that severity of agitation was significantly less than those who did not receive
music therapy when measured by a modified CMAI designed to assess severity (p=0.027).3
Another quantitative study done in acute care settings found opposing results (n=25). It was

discovered that frequency of agitation was lower during music therapy sessions when
measured by the Observed Emotion Rating Scale (p=0.045).15 A quantitative study focusing on
playing music during meal times, specifically in skilled nursing facilities was performed (n=22). It
was shown that music played at meal times decreased global agitation measured by the CMAI,
meaning patients had a more positive interaction with peers and were capable of engaging in a
group environment with fewer agitation symptoms (p<0.001).16 The study did not look at what
types of music specifically were best, so further studies would be needed to identify if certain
genres or time-periods were most impactful. These studies provide a mixed ideology of what
aspect of agitation itself is treated by music therapy. These data sets present further questions
for how exactly agitation is affected and whether or not music therapy can replace the function
of antipsychotics in all situations and environments.
Efficacy and Long-Term Impact
Duration of efficacy following music therapy has also been examined. All studies
analyzed that looked into long-term effects initially noted improvement, but varied on how long
improvement was sustained. One study (n=132) noted that two weeks following the
completion of their music therapy trial, reduction of agitation in patients with dementia was no
longer significant according to analysis of repeat CMAI scores (p>0.05), but still remained lower
than pre-trial levels (p=0.018).11 A similar quantitative study (n=39) looking into duration of
efficacy also noted BPSD increased two-weeks post therapy when assessed by the Behavioral
Pathology in Alzheimer’s Disease Rating Scale (p<0.025).13 Four weeks was the longest post-trial
assessment analyzed in this review. It was found that there was no difference between twoweeks and four-weeks post therapy participant (n=48) CMAI scores, but BPSD was higher than

when measured during treatment (p=0.02).17 Literature discussed thus far includes a wide
range of dementia severity, ranging from mild to severe. Two studies focused on the reduction
of agitation in patients specifically with severe dementia. Both found improvement in BPSD
during music therapy trials, but did not comment on the lasting impact.14,18 Lack of either
examination of efficacy or the data to support long-term efficacy weakens the argument for
music therapy to replace antipsychotics. The data does not support sustained efficacy and does
not propose therapy timelines. These missing recommendations make it challenging to suggest
a specific treatment plan for patients with agitation secondary to dementia.
Systematic Reviews
Two systematic reviews were included to obtain an overall representation of the
available data. One systematic review found differing results in regard to agitation. In an
analysis of six randomized controlled trials and five clinical trials, a decrease was noted (-0.49; 0.82 to -0.17).2 But when looking at a separate five randomized controlled trials and five clinical
trials, the same reviewers found no improvement. The systematic review also compared music
therapy to other modalities proposed to treat agitation in patients with dementia and found
that among sensory stimulation, only music therapy was shown to be effective. 2 Not all studies
pertaining to the efficacy of music therapy have demonstrated improvement in agitation. A
Cochrane review that amassed 515 participants found that there was no reduction in agitation
when patients utilized music therapy in place of antipsychotics.19 Although, through a further
comprehensive review article that focused on utilizing music as medicine, it has been suggested
that although music therapy is not as effective as antipsychotics, it does not carry the same
negative side effect profile.20 The differing results of these large systematic reviews reflect the

issue that purveys the previously analyzed articles. High quality research with large sample
sizes, standardized assessment tools, and long-term follow up are not available to identify the
true impact, or lack thereof, of music therapy on agitation. Study results are summarized in
Table 1.
Summary
The current literature incorporated into this review presents mixed evidence on
whether or not music therapy can be utilized as the primary treatment for agitation secondary
to dementia. Caregivers, families, and MTs are able to obtain a reduction in agitation using
various methods of music therapy, but results are not consistent, making it unclear if the
provider has an impact on the quality and efficacy of music therapy. Long-term follow up was
present in few studies, adding to the difficulty of creating a specific recommendation that
includes frequency, length, and type of music therapy aimed at reducing agitation in
individuals. Further research is necessary to guide this conversation and determine the exact
role of music therapy in this setting, but music therapy should still be offered as an option prior
to initiating antipsychotic medications based on the efficacy and lack of negative side effects
observed and demonstrated in certain individuals, populations, and settings.

Methods
Research was initiated through PubMed searches. Key terms included were ‘dementia’,
‘music therapy’, and ‘agitation’. Studies and articles were sorted by the most recent. An
intentional effort to review varying study models was made to include randomized controlled
trials, systematic reviews, review articles, and meta-analysis. Reference lists were reviewed and
articles were selected for further consideration.

Prior to selecting studies and articles for further review, the methods section of each
was analyzed to check for controls, validated scales, patient selection processes, and analysis
technique. No studies were excluded based on methods. Methodologic concerns are noted
within the discussion section.
Exclusion of studies was based on quality concerns. Papers with large grammatical or
spelling errors were omitted and not analyzed. Studies were omitted that did not have
references or were not peer reviewed. This has the potential to inflict bias, but it was
determined that this approach was better than including potentially poor data sets and
statistical analyses.
Accepted studies were read through entirely and information was extracted for
incorporation into this analysis. Results were compared to insure each side of the topic was
addressed, as well as to identify potential differences in the impact different methods of music
therapy (individualized vs generalized) may have. Following the extraction and comparison of
data, the data was compiled and results were interpreted for the use of medical providers.

Discussion
Music therapists have proposed their field as an answer to eliminate the need for, and
potential overuse of, antipsychotics. Current research is aimed at providing evidence for the
incorporation of music therapy in the treatment of agitation secondary to dementia. Many
facilities, both public and private, through the support of individual families, have already
begun utilizing music in the care plans of these patients. While multiple studies support this
approach, some studies do not demonstrate this same efficacy. It must be decided based on

current research, whether or not music therapy should be offered as the new standard of care
for this subunit of BPSD.
Current research supports the use of music therapy by both caregivers and music
therapists, however one must consider which approach is best. This determination will affect
how, when, and to whom providers can refer to for music therapy. Presently, there is no
research that suggests that the administrator impacts the outcomes, but it may be assumed, as
is true for most professions, that a trained individual would be capable of making informed
treatment choices and plans. This being said there are clear benefits for use of music therapy by
caregivers. This treatment could be used to bond and form a lasting meaningful relationship,
reducing emotional and psychological stress of the caregiver, while improving the QOL of the
patient throughout the end stages of dementia. Studies are needed to determine when and
how music therapy care can be transitioned from a trained professional to that of a lay person.
Selecting between the use of individualized or general music therapy is another topic
among researchers looking at treating agitation. Typically, current results demonstrate a
greater outcome when music has been tailored to meet the patient’s personal needs and
desires. However, one must acknowledge the time and effort needed to coordinate this level of
care. In comparison to generalized group therapy, an increase in staffing required to administer
individualized treatment to each patient would be required. In order to justify this allocation of
resources, studies must be completed that show a reduction in cost in other areas of care.
These areas might include hospital admissions secondary to injuries from BPSD symptoms,
psychological evaluations, and provider visits to adjust medications meant to control agitation
symptoms. Even though studies suggest that individualized music therapy is a better, it should

be examined whether or not generalized music therapy is adequate. This is similar to the
treatment of other chronic conditions in regard to the fact that they typically have a very
effective, expensive treatment, but also other options that are typically more affordable and
available to a larger percentage of patients while achieving reasonable outcomes.
Environment can impact a patient’s agitation severity and frequency and studies have
been done to look at music therapy’s role in varying situations. The research suggests that
music played during meal times or acute care stays may reduce agitation. However, this
assertion draws attention back to the idea of individualized versus generalized music therapy
previously discussed and once again the feasibility of such treatment in these scenarios. In a
dining setting, it is unclear how one would approach the task of identifying and selecting music
that would benefit all of those present. Currently, facilities would have to employ trial and
error. Studies presenting common calming themes would be needed to inform these choices.
Even more importantly, in an acute care setting, studies demonstrating how much time would
be needed to determine and administer the method of music therapy needed, in comparison to
that of administering a single medication. Evidence that outcomes are either the same or better
would be required before providers could justify replacing the use of oral and IV medications.
Although current studies generally support the use of music therapy in patients with
agitation secondary to dementia, they do not clearly answer questions of efficacy and longterm impact. There are still conflicting results when studies are compiled into systematic
reviews, creating further questions of whether or not music therapy should become the new
standard of care. The research shows that following the cessation of music therapy, BPSD
symptoms return. Even though this is not different than the continued need to use

antipsychotics when agitation returns, time and cost could be the deciding factor for providers
and insurance companies. Studies are missing that can demonstrate a specific, prescriptive
method that describes the frequency and schedule needed for music therapy to effectively
treat and maintain a patient’s BPSD status.
If music therapy is to replace antipsychotics as the mainstay of treatment its efficacy
should be equal to, or better than that of antipsychotics, or have benefits that far outweigh the
risks of antipsychotic use. It has been shown that music therapy, although not as effective as
antipsychotics, does not increase the risk of cardiovascular events and parkinsonism like the
current medical treatment. The lack of side effects may be particularly alluring to patients who
have a personal or family history of cardiac events and are looking to avoid increasing their risk.
It is then up to patients, families, and providers to decide since current research suggests there
may be some benefit but cannot draw any firm conclusions that exclude the need for
antipsychotic medication.
One consideration that addresses both the supporting and opposing data, is that
validated scales for measuring the impact of music therapy on BPSD are not widely available.
Researchers, like McDermot, have developed their own tools to assess agitation but these tools
are not universally utilized or accepted. The challenge that presents then when determining a
reduction in agitation is that of the subjective observer. People have different tolerances for
certain behaviors. Even when the same observer watches ten patients, their tolerance for each
person may vary depending on the patient’s personality, ability to form a relationship, and even
appearance, gender, race, or ethnicity. Without a validated and universal scale to assess
agitation, identifying a significant reduction may not be meaningful.

Conclusion
Music therapy should be considered an option in managing agitation in patients with
dementia that do not have any absolute indications for antipsychotics. It is easily administered
by caregivers and families in a home setting and may help maintain a healthy and supportive
relationship through the end stages of dementia. Skilled nursing facilities can use it during meal
times to keep more patients in the dining room, providing patients the benefit of social
engagement and maintained dignity. Although evidence for efficacy varies, there are no side
effects in the literature. Widespread use may provide an increase in QOL and a reduction in the
use of antipsychotic medications in which overuse has been criticized.
Ultimately, patient well-being should be the most important consideration when
choosing between music therapy and antipsychotics. Patients should be presented with
available information pertaining to music therapy and its use in patients with dementia. Figure
1 may be helpful to provide patients a brief summary of music therapy and the evidence behind
it. As with any condition, patients deserve to know all the available treatment options and the
evidence, risks, and benefits for each. Including music therapy as a modality, while maintaining
the understanding that the current best treatment is antipsychotics, would enhance the
patient-provider relationship and allow for a more informed, patient-centered decision.
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Appendix
Table 1. Summary of background literature review results and statistical analysis when available.
Boxes containing N/A indicate the information was not available.
Study Reference #
2

Sample size (n)
Study Method
Systematic Review of 6 RCTs and 5 CTs

3

42

Quantitative

8

12

Qualitative

9

42

Quantitative

10

17

Mixed-Method
Feasibility

11

132

Quantitative

12

45

Quantitative

13

N/A

Qualitative

14

39

Quantitative

15

25

Quantitative

16

22

Quantitative

17

48

Quantitative

18

22

Quantitative

19

Cochrane Review

Outcome
Reduction in
agitation
Reduction in
severity but not
frequency
Increase in nonaggressive behavior
Agitation lower
thirty minute after
music therapy
Decrease in
agitation between
baseline and seven
months
Group therapy
performed by music
therapists showed
reduction in
agitation
Reduction in
personal agitation,
but not significant
when compared to
control
Music based on
patient preference
showed greater
decrease in agitation
Interactive music is
more effective than
passive
Frequency of anger
lower during music
therapy sessions
Meal time music
increased nonaggressive behavior
BPSD symptoms
increase post-music
therapy but remain
below baseline
Music therapy for
agitation in patients
with severe
dementia
No reduction in
agitation

Statistical Analysis
-0.49 95% CI: -0.82
to -0.17
p=0.027
N/A
p<0.05
-25.52 95% CI: 39.1 to -11.95
p<0.05

p<0.05; p=0.432

N/A

p<0.025
p=0.045
N/A
p=0.02

P=0.031

N/A

Figure 1. Evidence Based Practice hand out.
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